Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-19-049172
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-11 16:30:49
Reporting Period:
2019-09-10
Accepted Time:
2019-09-11 16:30:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567514 Intra-Cellular Therapies Inc. ITCI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1299430 D Christopher Alafi C/o Alafi Capital Company, Llc
8 Admiral Drive, Suite 324
Emeryville CA 94608
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-10 3,549 $8.98 4,191,819 No 4 P Indirect Held by Alafi Capital Company, LLC
Common Stock Acquisiton 2019-09-10 155,116 $9.59 4,346,935 No 4 P Indirect Held by Alafi Capital Company, LLC
Common Stock Acquisiton 2019-09-10 320,095 $10.58 4,667,030 No 4 P Indirect Held by Alafi Capital Company, LLC
Common Stock Acquisiton 2019-09-10 6,240 $11.00 4,673,270 No 4 P Indirect Held by Alafi Capital Company, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Alafi Capital Company, LLC
No 4 P Indirect Held by Alafi Capital Company, LLC
No 4 P Indirect Held by Alafi Capital Company, LLC
No 4 P Indirect Held by Alafi Capital Company, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 341,223 Direct
Common Stock 503,753 Indirect Held as Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust
Common Stock 170,000 Indirect Held by Christopher D Alafi Family Trust
Footnotes
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.97 to $8.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
  3. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  5. Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
  6. Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.